HI homepage

venture capital money dollar funds VC
Venture capital investors have poured over $11B into radiology since 2000

The most funded categories across the specialty included medical devices ($3.2B), AI software ($2.5B), and biotechnology ($2.1B). 

Lumexa Imaging
Lumexa Imaging no longer controlled by private equity following IPO

“We view this as meaningfully credit positive for its financial policy because private equity investors tend to favor high leverage to enhance their returns,” S&P notes. 

IR Centers
Interventional radiology group inks 3 more urology practice partnerships across 3 states

IR Centers, a platform company dedicated to offering minimally invasive procedures in diverse outpatient settings, is teaming with doc groups in Alabama, Texas and Virginia. 

Congress Senate Washington D.C. DC
Radiologists, other specialists urge Congress to tap physician-owned hospitals in affordability talks

Over 40 medical societies including ACR are suggesting House lawmakers consider ending the 15-year ban on POHs. 

Philips agrees to acquire vascular imaging specialists SpectraWAVE
Philips to acquire company specializing in AI-powered intravascular imaging

Leaders at Philips are optimistic about how the new agreement could further advance its capabilities in image-guided coronary interventions. 

technologist remote scanning Philips Radiology Operations Command Center ROCC
'We've got to set the standard': Imaging leaders want safety at the forefront of remote operations

Perhaps the biggest sticking point in the debate around remote imaging operations relates to the bedside. If a technologist is running the exam remotely, who is tending to patients on-site? 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.